Wells Fargo & Company Voyager Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 64,318 shares of VYGR stock, worth $362,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,318
Previous 64,020 0.47%
Holding current value
$362,753
Previous $506,000 25.69%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$5.77 - $9.27 $1,719 - $2,762
298 Added 0.47%
64,318 $376,000
Q2 2024

Aug 13, 2024
BUY
$7.42 - $10.54 $46,597 - $66,191
6,280 Added 10.88%
64,020 $506,000
Q1 2024

May 10, 2024
BUY
$7.15 - $10.84 $343,378 - $520,591
48,025 Added 494.34%
57,740 $537,000
Q4 2023

Feb 09, 2024
BUY
$6.28 - $8.81 $11,762 - $16,501
1,873 Added 23.88%
9,715 $81,000
Q3 2023

Nov 13, 2023
SELL
$7.55 - $11.25 $53,756 - $80,100
-7,120 Reduced 47.59%
7,842 $60,000
Q2 2023

Aug 15, 2023
BUY
$6.94 - $13.99 $89,498 - $180,415
12,896 Added 624.2%
14,962 $171,000
Q1 2023

May 12, 2023
BUY
$6.0 - $10.78 $18 - $32
3 Added 0.15%
2,066 $15,000
Q4 2022

Feb 13, 2023
SELL
$4.94 - $6.61 $1,289 - $1,725
-261 Reduced 11.23%
2,063 $12,000
Q3 2022

Nov 14, 2022
SELL
$5.57 - $7.47 $14,431 - $19,354
-2,591 Reduced 52.72%
2,324 $13,000
Q2 2022

Aug 12, 2022
SELL
$4.82 - $10.09 $3,292 - $6,891
-683 Reduced 12.2%
4,915 $29,000
Q1 2022

May 16, 2022
SELL
$2.75 - $9.44 $76,961 - $264,187
-27,986 Reduced 83.33%
5,598 $42,000
Q4 2021

Feb 14, 2022
SELL
$2.47 - $5.55 $56,560 - $127,089
-22,899 Reduced 40.54%
33,584 $91,000
Q3 2021

Nov 15, 2021
SELL
$2.63 - $4.12 $115,088 - $180,291
-43,760 Reduced 43.65%
56,483 $148,000
Q2 2021

Aug 16, 2021
BUY
$3.94 - $5.44 $86,234 - $119,065
21,887 Added 27.93%
100,243 $414,000
Q1 2021

May 13, 2021
SELL
$4.61 - $9.04 $287,484 - $563,743
-62,361 Reduced 44.32%
78,356 $369,000
Q4 2020

Feb 09, 2021
SELL
$7.15 - $12.28 $2.09 Million - $3.6 Million
-292,847 Reduced 67.54%
140,717 $1.01 Million
Q3 2020

Nov 05, 2020
SELL
$10.01 - $13.75 $304,954 - $418,893
-30,465 Reduced 6.57%
433,564 $4.63 Million
Q2 2020

Aug 13, 2020
BUY
$8.05 - $14.21 $49,290 - $87,007
6,123 Added 1.34%
464,029 $5.86 Million
Q1 2020

May 14, 2020
BUY
$6.8 - $14.66 $3.11 Million - $6.71 Million
457,906 New
457,906 $4.19 Million

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $218M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email